Items Tagged ‘Dr. Doug Dolginow’

April 29, 2013

GenomeDx Expands Collaboration with Mayo Clinic

By Logan Lafferty Logan Lafferty

GenomeDx Biosciences announced today that it has expanded an existing research agreement with the Mayo Clinic. The expanded agreement includes exclusive license to certain Mayo developed intellectual property along with exclusivity covering co-developed intellectual property‚Ķ”Access to the Mayo Clinic’s comprehensive cohort of samples from patients classified as high risk for metastatic disease and the involvement […]

View full entry

Tags: Decipher, Dr. Doug Dolginow, GenomeDx Biosciences, intellectual property, metastatic disease, research agreement, Wall Street Journal


Contact Us · Privacy Policy